Accessibility Statement Skip Navigation
  • PRNewswire.com
  • Resources
  • +91 22-69790010
  • Client Login
  • Send a Release
PR Newswire: news distribution, targeting and monitoring
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please use Advanced Search to search all press releases.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • General Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • Telephone

    • +91 22-69790010 from 9 AM - 5:30 PM IST

    • Contact
    • Contact

      +91 22-69790010
      from 9 AM - 5:30 PM IST

  • When typing in this field, a list of search results will appear and be automatically updated as you type.

  • Request More Information
  • Journalists
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Request More Information
  • Journalists
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • Request More Information
  • Journalists
  • General Inquiries
  • Worldwide Offices
  • Request More Information
  • Journalists

LaennecAI launches Zorgm Pro: A free medical education answer engine built by doctors, for doctors
  • India - Hindi

Zörgm Pro Logo

News provided by

LaennecAI

01 Jun, 2026, 09:00 IST

Share this article

Share toX

Share this article

Share toX

A clinician-only "ChatGPT for doctors" supporting continuing medical education, self-learning, and evidence-based clinical updating in India and the UK

MUMBAI, India and LONDON, June 1, 2026 /PRNewswire/ -- LaennecAI today announced the launch of Zorgm Pro, a free medical education answer engine for verified doctors in India and the UK, designed to support continuing medical education, self-learning, and evidence-based clinical updating.

Addressing the Growing Need for Continuous Medical Learning

The main reason for Zorgm Pro is built around a simple clinical reality: doctors need to stay continuously updated to give patients the best possible care, but medical knowledge is now changing faster than traditional education alone can keep pace with. Guidelines are changing, diagnostic thresholds are being revised, drug safety information is evolving, antimicrobial resistance patterns are shifting, and new evidence is constantly reshaping clinical practice. 

This is why many clinicians are already turning to general-purpose AI for medical questions. However, general-purpose AI was not built specifically for clinical education. It can generate answers from broad model memory or open web content, without the strict evidence grounding, doctor-reviewed curation, source traceability, regional guideline alignment, and educational boundaries that doctors need. 

"Every doctor understands that staying current is part of giving patients the best possible care," said Dr Jase John, MBBS, MPH, Co-Founder of LaennecAI. "Zorgm Pro was created to support that responsibility with a trusted medical education answer engine built around evidence, traceability, regional relevance, and professional judgement. It is built by doctors, for doctors." 

Built on Curated, Evidence-Based Medical Intelligence

In medicine, speed alone is not enough. Doctors need to see where information comes from, assess the source, and apply their own professional judgement. 

Zorgm Pro does not search the open internet to generate medical answers. It uses retrieval-grounded AI to answer from a doctor-reviewed medical knowledge base of trusted clinical sources, guidelines, medicine information, and peer-reviewed literature. If the system does not find sufficient evidence in its curated sources, it is designed not to invent an answer. 

Zorgm Pro is free for verified doctors. Doctors in India can verify through their National Medical Commission registration, while doctors in the UK can verify through their General Medical Council registration. Zorgm Pro is designed with privacy at its core, and personal data is not shared with third-party companies. 

Regional relevance is central to Zorgm Pro. The platform's curated medical knowledge base brings together country-specific guidance, including Indian Council of Medical Research (ICMR) guidance and Ministry of Health and Family Welfare (MoHFW) guidance for India, alongside international guidelines, medicines information, FDA resources, US National Library of Medicine sources, and millions of curated medical and scientific papers. This allows doctors to ask clinical education questions through one familiar interface, while Zorgm Pro grounds its answers in sources that reflect both global evidence and the relevant local clinical context. 

"Medical evidence is vast, but volume alone is not enough," said Dr Arathy Varghese, PhD, Co-Founder of LaennecAI. "Zorgm Pro is designed to organise trusted guidelines, medicines information, international references, and peer-reviewed medical literature into a curated knowledge base that doctors can interrogate through a familiar conversational interface." 

Privacy, Verification, and Clinical Responsibility at the Core

Zorgm Pro is an educational reference tool for verified doctors. It is not a diagnostic tool, prescribing tool, triage system, bedside clinical decision-support system, or Software as a Medical Device. Doctors remain responsible for applying guidance to individual patients and verifying against local protocols, formularies, and clinical context. 

Zorgm Pro is now available at www.zorgm.pro and on iOS and Android for verified doctors in India and the UK, with plans to expand to additional countries and guideline frameworks over time. 

Frequently Asked Questions (FAQs)

What is Zorgm Pro?

Zorgm Pro is a free AI-powered medical education answer engine designed exclusively for verified doctors in India and the UK to support continuing medical education, self-learning, and evidence-based clinical updating.

Who can access Zorgm Pro?

Currently, verified doctors in India and the UK can access the platform using their NMC or GMC registrations respectively.

How is Zorgm Pro different from general AI tools?

Unlike general-purpose AI platforms, Zorgm Pro uses retrieval-grounded AI based on curated and doctor-reviewed medical sources rather than unrestricted internet content.

About LaennecAI 

LaennecAI is a medical AI company with teams across London, Cardiff, Birmingham, and Kochi. The company builds clinically focused AI tools for doctors and patients under the Zorgm brand. Its products include Zorgm Pro, a free clinician-only medical education answer engine for continuing medical education, self-learning, and evidence-based reference, alongside patient-facing self-management technologies and an AI as Medical Device digital stethoscope for respiratory and cardiac monitoring. 

LaennecAI's approach is grounded in curated medical sources, clinical governance, privacy, and regional relevance. 

www.laennec.ai

Logo - https://mma.prnewswire.com/media/2989468/Zorgm_Pro_Logo.jpg

Modal title

Also from this source

LaennecAI ने Zorgm Pro लॉन्च किया: डॉक्टरों की आवश्यकताओं को ध्यान में रखकर डॉक्टरों द्वारा तैयार किया गया एक निःशुल्क चिकित्सा-शिक्षा उत्तर इंजन

LaennecAI ने Zorgm Pro लॉन्च किया: डॉक्टरों की आवश्यकताओं को ध्यान में रखकर डॉक्टरों द्वारा तैयार किया गया एक निःशुल्क चिकित्सा-शिक्षा उत्तर इंजन

LaennecAI ने आज Zorgm Pro के शुभारंभ की घोषणा की, यह भारत और UK के सत्यापित (वेरिफ़ाइड) चिकित्सकों के लिए एक निःशुल्क चिकित्सा-शिक्षा उत्तर इंजन है,...

More Releases From This Source

Explore

Education

Education

Health Care & Hospitals

Health Care & Hospitals

Computer & Electronics

Computer & Electronics

Medical Pharmaceuticals

Medical Pharmaceuticals

News Releases in Similar Topics

Contact PR Newswire

  • +91 22-69790010

Global Sites

  • APAC
  • APAC - Traditional Chinese
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany

 

  • India
  • Indonesia
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland

 

  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921
Global Sites
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States
+91 (0) 22 6169 6000
from 9 AM - 5:30 PM IST
  • Terms of Use
  • Privacy Policy
  • GDPR
  • Information Security Policy
  • Site Map
  • Cookie Settings
Copyright © 2026 Cision US Inc.